Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus ointment in pediatric atopic dermatitis
NCT00691262Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2003
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Tacrolimus Ointment 0.1% Iwaki in atopic dermatitis (AD), sponsored by Astellas Pharma. Primary endpoint: Rate of patients with at least 50% improvement in Physician's Global Evaluation at 6 months. Started Oct 2003; status: completed.
02
Drugs
Tacrolimus Ointment 0.1% Iwaki
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT00691262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00691262.